Skip to main content
. 2022 Mar 29;14(7):1745. doi: 10.3390/cancers14071745

Table 6.

Impact of clinical and pathological variables on survival, follow-up and respiratory complications. ASA: American Society of Anesthesiologists classification of physical status. COPD: Chronic Obstructive Pulmonary Disease. Mean ± 95% CI: 95% Confidence Interval.

Features Postoperative Death Postoperative Complications Respiratory Complications
Yes No p-Value No Minor Major p-Value Yes No p-Value
Age, years 72.91 ± 4.98 66.59 ± 9.81 0.031 65.93 ±9.94 67.85 ± 9.89 69.00 ± 8.17 <0.001 69.36 ± 8.29 66.49 ± 9.86 0.0079
Gender: n (%)
Men 10 (0.93) 606 (56.27) 0.049 367 (34.08) 61 (5.66) 33 (3.06) <0.001 51 (4.73) 565 (52.46) <0.001
Women 1 (0.09) 460 (42.71) 384 (35.65) 131 (12.16) 101 (9.39) 13 (1.21) 448 (41.60)
BMI (kg/m2) 28.14 ± 4.88 25.24 ± 5.03 0.055 25.36 ± 5.05 25.20 ± 4.93 24.91 ± 5.04 0.64 25.72 ±5.68 25.24 ± 4.99 0.51
Smoking status: n (%) 0.94 0.011 0.0063
Current 3 (0.28) 328 (30.65) 225 (21.03) 61 (5.70) 45 (4.21) 24 (2.24) 307 (28.69)
Former 6 (0.56) 567 (52.99) 386 (36.07) 107 (10.00) 80 (7.48) 39 (3.64) 534 (49.91)
Never 2 (0.19) 164 (15.33) 134 (12.52) 23 (2.15) 9 (0.84) 1 (0.09) 165 (15.43)
FEV1 (% of predicted) 68.27 ± 24.51 88.09 ± 20.52 0.0017 90.86 ± 19.73 81.70 ±21.16 80.33 ±21.08 <0.001 77.00 ± 19.23 88.58 ± 20.56 <0.001
FVC (% of predicted) 75.75 ± 11.67 97.39 ± 19.53 0.0020 99.71 ± 18.51 91.61 ± 20.94 90.21 ± 20.35 <0.001 87.93 ±19.94 97.69 ± 19.44 0.0026
DLCO (% of predicted) 61.22 ± 16.07 68.22 ± 18.05 0.16 69.96 ± 17.51 66.22 ± 17.78 61.41 ± 19.22 <0.001 61.41 ± 21.59 68.58 ± 17.69 0.031
Ischemic Heart Disease: n (%) 0.49 0.011 0.19
Yes 1 (0.09) 239 (22.21) 153 (14.22) 44 (4.09) 43 (4.00) 10 (0.93) 230 (21.38)
no 10 (0.93) 826 (76.77) 597 (55.48) 148 (13.75) 91 (8.46) 54 (5.02) 782 (72.67)
Chronic obstructive pulmonary disease: n (%)
Yes 7 (0.66) 412 (38.25) 0.17 255 (23.68) 87 (8.08) 77 (7.15) <0.001 38 (3.53) 381 (35.38) <0.001
no 4 (0.37) 654 (60.72) 496 (46.05) 105 (9.75) 57 (5.29) 26 (2.41) 632 (58.68)
Score ASA: n (%)
I 1 (0.09) 409 (37.98) 0.048 309 (28.69) 57 (5.29) 44 (4.09) <0.001 11 (1.02) 399 (37.05) <0.001
II 5 (0.46) 445 (41.33) 323 (29.99) 82 (7.61) 45 (4.18) 22 (2.04) 428 (39.74)
III 5 (0.46) 212 (19.68) 119 (11.05) 53 (4.92) 45 (4.18) 31 (2.88) 186 (17.27)
Thoracoscore 4.59 ± 3.26 2.20 ± 1.84 0.0024 1.96 ± 1.42 2.71 ± 2.55 3.06 ± 2.49 <0.001 3.44 ± 2.87 2.16 ± 1.78 <0.001
Pneumonectomy: n (%)
Yes 2 (0.19) 64 (5.94) 0.30 31 (2.88) 24 (2.23) 11 (1.02) <0.001 3 (0.28) 63 (5.85) 0.82
No 9 (0.83) 1002 (93.04) 720 (66.85) 168 (15.60) 123 (11.42) 61 (5.66) 950 (88.21)
Histology: (n = 1069): n (%) 0.094 <0.001 <0.001
Neuroendocrine 3 (0.28) 87 (8.14) 69 (6.45) 10 (0.94) 11 (1.03) 4 (0.37) 86 (8.05)
Adenocarcinoma 5 (0.47) 709 (66.32) 521 (48.74) 119 (11.13) 74 (6.92) 31 (2.90) 683 (63.89)
Epidermoid 3 (0.28) 207 (19.37) 119 (11.13) 50 (4.68) 41 (3.83) 26 (2.43) 184 (17.22)
Others - 55 (5.16) 37 (3.46) 10 (0.94) 8 (0.75) 3 (0.28) 52 (4.86)
pT: n (%) 0.94 0.58 0.17
1 (a, b, c) 5 (0.46) 491 (45.59) 355 (32.96) 87 (8.08) 54 (5.01) 27 (2.50) 469 (43.55)
2 (a, b) 4 (0.37) 326 (30.27) 231 (21.45) 57 (5.29) 42 (3.90) 15 (1.39) 315 (29.25)
3 1 (0.09) 162 (15.04) 109 (10.12) 32 (2.97) 22 (2.04) 14 (1.30) 149 (13.84)
4 1 (0.09) 87 (8.09) 56 (5.20) 16 (1.49) 16 (1.49) 8 (0.74) 80 (7.43)